...
首页> 外文期刊>Frontiers in Cellular Neuroscience >Recombinant Adeno-Associated Virus Serotype 6 (rAAV6) Potently and Preferentially Transduces Rat Astrocytes In vitro and In vivo
【24h】

Recombinant Adeno-Associated Virus Serotype 6 (rAAV6) Potently and Preferentially Transduces Rat Astrocytes In vitro and In vivo

机译:重组腺相关病毒血清型6(rAAV6)有效地和优先地转导大鼠星形胶质细胞体外体内

获取原文
           

摘要

Recombinant adeno-associated virus vectors are an increasingly popular tool for gene delivery to the CNS because of their non-pathological nature, low immunogenicity, and ability to stably transduce dividing and non-dividing cells. One of the limitations of rAAVs is their preferential tropism for neuronal cells. Glial cells, specifically astrocytes, appear to be infected at low rates. To overcome this limitation, previous studies utilized rAAVs with astrocyte-specific promoters or assorted rAAV serotypes and pseudotypes with purported selectivity for astrocytes. Yet, the reported glial infection rates are not consistent from study to study. In the present work, we tested seven commercially available recombinant serotypes– rAAV1, 2, and 5 through 9, for their ability to transduce primary rat astrocytes [visualized via viral expression of green fluorescent protein (GFP)]. In cell cultures, rAAV6 consistently demonstrated the highest infection rates, while rAAV2 showed astrocytic transduction in some, but not all, of the tested viral batches. To verify that all rAAV constructs utilized by us were viable and effective, we confirmed high infectivity rates in retinal pigmented epithelial cells (ARPE-19), which are known to be transduced by numerous rAAV serotypes. Based on the in vitro results, we next tested the cell type tropism of rAAV6 and rAAV2 in vivo , which were both injected in the barrel cortex at approximately equal doses. Three weeks later, the brains were sectioned and immunostained for viral GFP and the neuronal marker NeuN or the astrocytic marker GFAP. We found that rAAV6 strongly and preferentially transduced astrocytes (>90% of cells in the virus-infected areas), but not neurons (~10% infection rate). On the contrary, rAAV2 preferentially infected neurons (~65%), but not astrocytes (~20%). Overall, our results suggest that rAAV6 can be used as a tool for manipulating gene expression (either delivery or knockdown) in rat astrocytes in vivo .
机译:重组腺伴随病毒载体由于其非病理学性质,低免疫原性和稳定地转导分裂和非分裂细胞的能力,是用于基因递送至CNS的越来越流行的工具。 rAAV的局限性之一是其对神经元细胞的嗜性。胶质细胞,特别是星形胶质细胞,似乎感染率很低。为了克服这一局限性,先前的研究利用了星形胶质细胞特异性启动子的rAAV,或对星形胶质细胞具有选择性的各种rAAV血清型和假型。然而,报道的神经胶质感染率在研究之间并不一致。在本工作中,我们测试了7种市售重组血清型-rAAV1、2和5至9,它们具有转导大鼠原代星形胶质细胞的能力[通过绿色荧光蛋白(GFP)的病毒表达可见)。在细胞培养物中,rAAV6始终显示出最高的感染率,而rAAV2在部分(而非全部)测试病毒批次中显示出星形细胞转导。为了验证我们使用的所有rAAV构建体都是可行和有效的,我们证实了视网膜色素上皮细胞(ARPE-19)的高感染率,已知该色素可通过多种rAAV血清型进行转导。根据体外结果,我们接下来在体内测试了rAAV6和rAAV2的细胞类型趋向性,它们均以大约相等的剂量注射到桶状皮质中。三周后,将大脑切成薄片,并对病毒GFP和神经元标记NeuN或星形细胞标记GFAP进行免疫染色。我们发现,rAAV6强烈且优先地转导了星形胶质细胞(在病毒感染区域中占90%以上的细胞),而不是神经元(感染率约10%)。相反,rAAV2优先感染神经元(〜65%),而不是星形胶质细胞(〜20%)。总体而言,我们的结果表明,rAAV6可用作体内大鼠星形胶质细胞中基因表达(传递或敲低)的工具。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号